BOSTON, May 14, 2014 /PRNewswire/ -- PAREXEL
International Corporation (NASDAQ: PRXL) announced today that it
will be presenting at the UBS Healthcare Conference in New York, NY. James
Winschel, Executive Vice President, will be making a
presentation on PAREXEL and discussing business developments at
8:30 a.m. EDT on Wednesday, May 21, 2014.
A live webcast of the presentation will be available through the
"Investors" section of PAREXEL's website at www.PAREXEL.com
in the Upcoming Events portion of the main page, and a replay of
the presentation will be available on the website until
August 21, 2014.
About PAREXEL International
PAREXEL International Corporation is a leading global
biopharmaceutical services organization, providing a broad range of
knowledge-based contract research, consulting, medical
communications, and technology solutions and services to the
worldwide pharmaceutical, biotechnology and medical device
industries. Committed to providing solutions that expedite
time-to-market and peak-market penetration, PAREXEL has developed
significant expertise across the development and commercialization
continuum, from drug development and regulatory consulting to
clinical pharmacology, clinical trials management, medical
education and reimbursement. Perceptive Informatics, Inc., a
subsidiary of PAREXEL, provides advanced technology solutions,
including medical imaging, to facilitate the clinical development
process. Headquartered near Boston,
Massachusetts, PAREXEL operates in 75 locations in 50
countries around the world, and has approximately 15,335 employees.
For more information about PAREXEL International visit
www.PAREXEL.com.
PAREXEL, PAREXEL Informatics, Perceptive, Perceptive MyTrials,
and "Your Journey. Our Mission." are trademarks or registered
trademarks of PAREXEL International Corporation or its
affiliates.
Contact:
Jill Baker, Corporate Vice
President, Investor Relations
PAREXEL International
Tel: +781-434-4118
Email: Jill.Baker@parexel.com
SOURCE PAREXEL International Corporation